IBRX Stock Gains Pre-Market After A Volatile Trading Session Following Phase 2 Glioblastoma Trial Update: Retail Backs ImmunityBio’s Cancer Research
Patrick Soon Shiong, ImmunityBio’s founder, took to X on Saturday to clarify what the update signified.